GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Transcat Inc (NAS:TRNS) » Definitions » Debt-to-EBITDA

Transcat (Transcat) Debt-to-EBITDA : 0.68 (As of Dec. 2023)


View and export this data going back to 1990. Start your Free Trial

What is Transcat Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Transcat's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $5.2 Mil. Transcat's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $16.9 Mil. Transcat's annualized EBITDA for the quarter that ended in Dec. 2023 was $32.5 Mil. Transcat's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.68.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Transcat's Debt-to-EBITDA or its related term are showing as below:

TRNS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.76   Med: 1.69   Max: 2.43
Current: 0.76

During the past 13 years, the highest Debt-to-EBITDA Ratio of Transcat was 2.43. The lowest was 0.76. And the median was 1.69.

TRNS's Debt-to-EBITDA is ranked better than
77.34% of 128 companies
in the Industrial Distribution industry
Industry Median: 2.095 vs TRNS: 0.76

Transcat Debt-to-EBITDA Historical Data

The historical data trend for Transcat's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcat Debt-to-EBITDA Chart

Transcat Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.27 2.12 1.48 2.43 2.28

Transcat Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.74 1.80 2.10 3.44 0.68

Competitive Comparison of Transcat's Debt-to-EBITDA

For the Industrial Distribution subindustry, Transcat's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transcat's Debt-to-EBITDA Distribution in the Industrial Distribution Industry

For the Industrial Distribution industry and Industrials sector, Transcat's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Transcat's Debt-to-EBITDA falls into.



Transcat Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Transcat's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.248 + 59.829) / 27.203
=2.28

Transcat's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.194 + 16.868) / 32.46
=0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Transcat  (NAS:TRNS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Transcat Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Transcat's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Transcat (Transcat) Business Description

Traded in Other Exchanges
N/A
Address
35 Vantage Point Drive, Rochester, NY, USA, 14624
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
Executives
Lee D. Rudow officer: Chief Operating Officer C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
James M. Jenkins officer: Gen Counsel & VP of Corp Devt 1600 BAUSCH & LOMB PLACE, ROCHESTER NY 14604
Craig D. Cairns director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Dawn Deperrior director 45 SOUTH MAIN STREET, FAIRPORT NY 14450
Christopher P. Gillette director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Charles P Hadeed officer: VP-Finance and CFO 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Scott Deverell other: Principal Accounting Officer 100 CHESTNUT STREET, SUITE 600, ROCHESTER NY 14604
Richard J Harrison director 44 SOUTHERN PARKWAY, ROCHESTER NY 14618
Theresa A. Conroy officer: VP, Human Resources C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Cynthia Langston director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Thomas L Barbato officer: Sr. VP Finance & CFO 105 NORTON STREET, NEWARK NY 14513
Carl E Sassano director, officer: Chairman, President and CEO C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Gary J. Haseley director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Michael W. West officer: VP Distribution & Marketing C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624
Mbago M. Kaniki director C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER NY 14624